Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation of Earnings Call

October 23, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, “Exchange Plaza”, Corporate Relationship Department, 5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring, Bandra- Kurla Complex Bandra (East), Mumbai P.J. Towers, Dalal Street, – 400 051 Mumbai – 400 001 NSE Symbol: GLENMARK Scrip Code: 532296 ISIN: INE935A01035 ISIN: INE935A01035 Our Reference No. 62/26-27 Our Reference No. 62/26-27 Dear Sir/ Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of Earnings Call With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Earnings Call on Unaudited Financial Results for the quarter ended September 30, 2026, is scheduled to be held as per the details below: Day Friday Date November 06, 2026 Time 8:30 am – 9:30 am [IST] Request you to kindly take the same on record. Thanking You. Yours faithfully, For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS - 28839 Encl: As above Glenmark Pharmaceuticals Limited Glenmark House, B. D. Sawant Marg, Andheri (East), Mumbai 400 099, India T: +91 22 4018 9999 F: +91 22 4018 9986 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com I N V I T AT I O N I N V I T AT I O N Glenmark Pharmaceuticals Ltd. Q2 FY 2027 Results Earnings Call Friday, 06 November 2026 8:30 am – 9:30 am [IST] Dial – in Numbers: Universal Access Number: +91 22 6280 1298 | +91 22 7115 8199 USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448 For any clarification, please contact: Utkarsh Gandhi / Purvi Shah +91 22 4018 9232 / +91 4018 9879 To pre-register online click here utkarsh.gandhi3@glenmarkpharma.com Purvi.Shah@glenmarkpharma.com